← FDA Drug Approvals (Drugs@FDA)

OPTIMARK

NDA · New Drug Application · Sponsor: LIEBEL-FLARSHEIM · Approved 1999-12-08

Drug application

FDA Application #

NDA020937

Application type

New Drug Application

Brand name

OPTIMARK

Generic name

Gadoversetamide

Active ingredients

GADOVERSETAMIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

LIEBEL-FLARSHEIM

First approval

1999-12-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown